China Introduces Dongbi Index to Challenge Impact Factor in Global Academic Rankings

China has introduced a new way to evaluate academic journals. The system is called the Dongbi Index ranking. It focuses on research quality instead of the traditional impact factor. Therefore, it aims to offer a more balanced view of global research.
Researchers unveiled the Dongbi Index lists in Shanghai on March 21. These lists include thousands of medical and life science journals. In addition, experts developed the system with support from major Chinese institutions. As a result, the project reflects a large and detailed global analysis.

A New Way to Measure Research Quality

The Dongbi Index uses a different approach from older methods. For example, it studies citation quality instead of just counting citations. Therefore, it looks at how strong and reliable research connections are.
Experts explain that high-quality research usually cites other high-quality work. Based on this idea, the system builds a large citation network. In addition, it groups journals into four levels: A, B, C, and D. This structure helps researchers understand journal quality more clearly.
Wu Dengsheng, one of the developers, said the system moves beyond simple metrics. He explained that it helps reduce reliance on the impact factor. However, he also noted that the goal is not to rank journals in a strict sense. Instead, the system reflects how researchers evaluate work in real fields.
Experts also point out issues with the traditional impact factor. For example, it can be influenced by citation patterns and manipulation. Therefore, some researchers believe it does not fully represent true research quality. The Dongbi Index aims to address these concerns.

China’s Growing Role in Global Research

The report highlights China’s strong contribution to global science. For instance, Chinese researchers produced nearly one-third of all life science papers. In addition, they contributed about 21% of medical research articles in recent data.
China shows particular strength in areas like pharmacology and biotechnology. However, challenges still remain. Many Chinese journals fall into lower ranking categories. Therefore, top research from China often appears in foreign journals.
Experts also note a lack of top-tier Chinese journals in some fields. For example, areas like dermatology and pathology still lack strong domestic platforms. As a result, international publishers continue to dominate academic influence.
Despite these challenges, China continues to expand its research ecosystem. New journals and alliances aim to boost global recognition. Therefore, the Dongbi Index may play a key role in shaping future academic standards.